PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FSMEX vs. FPHAX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

FSMEX vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
5.92%
-6.85%
FSMEX
FPHAX

Returns By Period

In the year-to-date period, FSMEX achieves a 9.80% return, which is significantly lower than FPHAX's 13.18% return. Over the past 10 years, FSMEX has outperformed FPHAX with an annualized return of 6.21%, while FPHAX has yielded a comparatively lower 3.18% annualized return.


FSMEX

YTD

9.80%

1M

1.75%

6M

5.92%

1Y

20.24%

5Y (annualized)

3.11%

10Y (annualized)

6.21%

FPHAX

YTD

13.18%

1M

-8.54%

6M

-6.85%

1Y

17.79%

5Y (annualized)

4.43%

10Y (annualized)

3.18%

Key characteristics


FSMEXFPHAX
Sharpe Ratio1.311.11
Sortino Ratio1.891.61
Omega Ratio1.231.20
Calmar Ratio0.540.96
Martin Ratio4.753.68
Ulcer Index4.26%4.84%
Daily Std Dev15.40%16.02%
Max Drawdown-43.45%-37.34%
Current Drawdown-23.85%-15.55%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FSMEX vs. FPHAX - Expense Ratio Comparison

FSMEX has a 0.68% expense ratio, which is lower than FPHAX's 0.75% expense ratio.


FPHAX
Fidelity Select Pharmaceuticals Portfolio
Expense ratio chart for FPHAX: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for FSMEX: current value at 0.68% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.68%

Correlation

-0.50.00.51.00.7

The correlation between FSMEX and FPHAX is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Risk-Adjusted Performance

FSMEX vs. FPHAX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FSMEX, currently valued at 1.31, compared to the broader market-1.000.001.002.003.004.005.001.311.11
The chart of Sortino ratio for FSMEX, currently valued at 1.89, compared to the broader market0.005.0010.001.891.61
The chart of Omega ratio for FSMEX, currently valued at 1.23, compared to the broader market1.002.003.004.001.231.20
The chart of Calmar ratio for FSMEX, currently valued at 0.54, compared to the broader market0.005.0010.0015.0020.000.540.96
The chart of Martin ratio for FSMEX, currently valued at 4.75, compared to the broader market0.0020.0040.0060.0080.00100.004.753.68
FSMEX
FPHAX

The current FSMEX Sharpe Ratio is 1.31, which is comparable to the FPHAX Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of FSMEX and FPHAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
1.31
1.11
FSMEX
FPHAX

Dividends

FSMEX vs. FPHAX - Dividend Comparison

FSMEX has not paid dividends to shareholders, while FPHAX's dividend yield for the trailing twelve months is around 0.75%.


TTM20232022202120202019201820172016201520142013
FSMEX
Fidelity Select Medical Technology and Devices Portfolio
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%11.71%5.17%9.84%
FPHAX
Fidelity Select Pharmaceuticals Portfolio
0.75%0.63%1.33%1.17%1.31%1.31%1.44%1.33%1.07%5.59%5.81%11.12%

Drawdowns

FSMEX vs. FPHAX - Drawdown Comparison

The maximum FSMEX drawdown since its inception was -43.45%, which is greater than FPHAX's maximum drawdown of -37.34%. Use the drawdown chart below to compare losses from any high point for FSMEX and FPHAX. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-23.85%
-15.55%
FSMEX
FPHAX

Volatility

FSMEX vs. FPHAX - Volatility Comparison

The current volatility for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) is 3.70%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 6.50%. This indicates that FSMEX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%JuneJulyAugustSeptemberOctoberNovember
3.70%
6.50%
FSMEX
FPHAX